Literature DB >> 39764

Methods for evaluation of urinary excretion parameters of alclofenac after I.M. administration of its water soluble lysine salt in man.

R Testa, R Latini.   

Abstract

The urinary excretion data after I.M. administration of water soluble lysine salt of Alclofenac were analysed by the techniques suggested by Niebergall, Wagner, Martin and Cummings. All methods used give similar estimates of both DU infinity and Kel with exception of the "Sigma minus" method when DU infinity obtained by "Rate Method" was utilized. Niebergall's method is preferred on the basis that it provides an accurate estimation of both DU infinity and Kel. These parameters, evaluated after administration of Alclofenac-lysinate, resulted in agreement with previously reported data obtained after administration of different pharmaceuticals of acidic drug.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39764     DOI: 10.1007/BF03189407

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

1.  Rapid methods for bioavailability determination utilizing urinary excretion data.

Authors:  P J Niebergall; E T Sugita; R L Schnaare
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

2.  Effect of food on kinetics of the nonsteroidal anti-inflammative, alclofenac.

Authors:  L T Sennello; R C Sonders; N Friedman
Journal:  Clin Pharmacol Ther       Date:  1978-04       Impact factor: 6.875

3.  Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

Authors:  J G Wagner; J W Ayres
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 4.  The chemical and biological background to alclofenac.

Authors:  L F Wiggins
Journal:  Curr Med Res Opin       Date:  1975       Impact factor: 2.580

5.  Pharmacokinetics and availability of alclofenac in man after the administration of different pharmaceutical forms and doses.

Authors:  R Testa
Journal:  Farmaco Prat       Date:  1978-08

6.  Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

7.  Evaluation of alclofenac treatment regimes in man.

Authors:  M S Benedetti; P Strolin; R Roncucci; M J Simon; G Lambelin; C Nagant de Deuxchaisnes
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

8.  Drug urinary excretion data--some aspects concerning the interpretation.

Authors:  B K Martin
Journal:  Br J Pharmacol Chemother       Date:  1967-02

9.  A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man.

Authors:  A J Cummings; M L King; B K Martin
Journal:  Br J Pharmacol Chemother       Date:  1967-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.